摘要
目的探讨依托考昔与塞来昔布治疗急性痛风的疗效与安全性。方法随机选取该院2013年4月—2014年6月收治的80例急性通风患者,并将其随机分为实验组与对照组,各40例。其中实验组患者采用依托考昔进行口服治疗;对照组患者采用塞来昔布进行口服治疗。对比两组通风患者的各项数据。结果两组急性痛风患者进行治疗后发现,实验组患者的其他各项指标均优于对照组患者。两组急性痛风患者治疗后的VAS评分存在明显差异,P<0.05,差异有统计学意义。结论依托考昔能够有效的对急性痛风患者进行治疗,具有安全性高、起效快等优点,值得临床推广使用。
Objective To investigate the efficacy and safety of etoricoxib and celecoxib in the treatment of acute gout. Methods 80 cases of acute ventilation were selected from April 2013 to June 2014, and were randomly divided into experimental group and control group, 40 cases in each group. In the experimental group were treated with etoricoxib oral treatment; the control group were treated with celecoxib oral treatment. Compare the data of two groups of ventilation patients. Results Two groups of patients with acute gout were treated, the other indicators of the experimental group were better than those of the control group. There were significant differences in VAS score between the two groups after treatment, P<0.05, the difference was statistically significant. Conclusion Relying on past exam can effectively in patients with acute gout treatment, which has the advantages of high safety, fast action and so on, worthy of clinical use.
出处
《中外医疗》
2015年第28期156-157,共2页
China & Foreign Medical Treatment
